EFIC and the European Academy of Neurology (EAN) are co-organising a session at the EAN congress on the use of cannabinoids for chronic pain. The ‘controversies’ session will be addressed by EFIC Board member Prof. Elon Eisenberg.
‘The use of cannabinoids for chronic pain is increasing worldwide, but whether it should indeed be recommended in the therapeutic algorithm, or whether it is too early to recommend for current use, is still debated.’
The session will take place on Sunday 24 May 2020 between 16:45 and 17:30. The congress will take place in Paris, France.
